StockWatch
·

Medi Assist Healthcare Services Ltd Q2 FY27 Results

MEDIASSISTQ2 FY27 Results
Filing
Result:Very Good· Market: Up#Margin expansion#Broad based

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue241.512.1%3.9%
Total Income245.360.7%4.5%
Expenditure215.631.7%2.6%
PBT29.7314.8%120.8%
Net Profit21.5821.8%167.5%
OPM20.38%0.08pp3.30pp
NPM8.79%2.38pp5.35pp
EPS2.8822.4%154.9%
View full financials

PAT up 167.5% YoY on only modest premium/revenue growth (3.9%) but with strong operating leverage (OPM 17.1%→20.4%), so capped below top-tier since core topline growth is muted despite the sharp margin-driven profit jump.

MEDI ASSIST · Q2 FY27 · THE VERDICT

Margin Recovery Can't Hide Revenue Stall

Reported profit surged 167.5%, but operating revenue grew just 3.9%—a critical miss against the prior 14% industry benchmark. With retention down and same-store growth halved, the fundamentals behind management's '3-4 quarter recovery' narrative need scrutiny.

06 Nov 2026 · 6 min read
Reported Q2 PAT

₹21.6 Cr

+167.5% YoY

Q2 operating revenue

₹241.5 Cr

+3.9% YoY vs. 14% target

EBITDA margin Q2

20.4%

+331 bps YoY

Group retention H1

90.5%

vs. prior 93-94%

Profit surged, but revenue stalled

Q2 reported PAT of ₹21.6 Cr jumped 167.5% year-on-year, lifted by Paramount integration lapping and margin expansion. But peel back the headline: operating revenue grew just 3.9%—a deep miss against management's prior claim of '14% industry growth or better.' TPA revenue, the core business, expanded only 1.2% in Q2, the slowest rate of the recent cycle. Management invokes a 3-4 quarter accounting lag on installment premium recognition, citing contract liability of ₹321.7 Cr (vs. ₹280.2 Cr in FY26). If true, this deferred revenue will catch up. But the underlying TPA growth dynamic has fundamentally slowed—same-store growth halved from 13-14% to 7-8%, driven by IT-ITeS headcount saturation and benefit inflation in the market.

Where the profit came from

The PAT lift is real, but its drivers matter for the outlook. Q2 margin expanded 331 basis points to 20.4%, delivered on management's four-quarter Paramount integration promise. But much of the profit growth is non-recurring: H1 PAT benefited from a one-time derivative gain on call-put options, and the comparison is easy because Paramount churn was severe in prior-year Q2. Strip these out, and organic H1 PAT of roughly ₹46 Cr (vs. reported ₹49.2 Cr) grows only about 50% from prior H1's ₹30.7 Cr—still solid, but not the 167% headline.

Management's key claims vs. what the numbers show

Core business growth 'in line with or better than industry (14%)'

Contradicted

Q2 operating revenue +3.9% YoY; India TPA +11.9% H1 but only +1.2% Q2

Paramount integration complete Q2 with 330 bps margin improvement

Supported

Integration complete; 331 bps EBITDA margin expansion achieved YoY

Technology scaling 55% YoY, targeting ~10% of revenue

Partial

Platform ₹19.8 Cr H1 (4.2% of consolidated), 69.8% growth; still far from target

Retention recovering to 93-94% in 3-4 quarters

Partial

H1 retention 90.5%; improvement Q/Q but timeline extended

International business expanding, Thailand platform live

Partial

H1 international growth only 1.1% YoY; early-stage, no material near-term impact

What changed from prior guidance

Management has reset the growth narrative without providing numbers. Prior call promised '14% industry growth or better'; this call backed away to 'per or faster than market' with no numeric target. Margin steady-state target remains 22-23%, implying 180+ basis points of uplift still to come from the current 20.4%. Retention recovery is now a 3-4 quarter process (previously implied Q2 normalization), citing both Paramount churn and a December cyber incident as persistent headwinds. Same-store growth structural decline from 13-14% to 7-8% is reframed as an industry-wide dynamic (IT-ITeS saturation, benefit inflation), but no offset strategy was articulated. International business remains flat at 1.1% H1 growth despite Thailand platform launch—early stage, no near-term catalyst.

Bull-bear ledger

  • Paramount integration margin lift delivered (330 bps), on schedule

  • PAT grew 167.5% YoY, showing operational leverage

  • Group market share improved to 34.1%; scale advantage intact

  • Zero debt; cash ₹268.3 Cr; net worth ₹886.8 Cr; strong balance sheet

  • Technology platform at scale (7M claims H1); long-term SaaS runway exists

  • Revenue growth missed guidance badly (3.9% Q2 vs. 14% prior claim)

  • TPA core growth collapsed to 1.2% Q2, raising questions on accounting lag narrative

  • Retention down to 90.5% from 93-94%; recovery timeline vague (3-4 quarters)

  • Same-store growth halved to 7-8% from 13-14%; structural headwind unaddressed

  • Technology monetization delayed; still 4.2% of revenue vs. 10% target

  • Management guidance reset without numbers; no quantified FY27 targets

Ranked risks (by concern to a holder)

Risks ordered by severity of impact

TPA growth accounting lag masks structural deceleration

High

Q2 TPA growth only 1.2% YoY (₹219.6 Cr). Management cites 3-4 quarter revenue recognition lag on installment premiums with ₹321.7 Cr contract liability. If deferred revenue doesn't materialize as claimed, or if core TPA growth stays below 8%, the guidance miss becomes permanent, not temporary.

Retention recovery timeline extended and uncertain

High

H1 retention at 90.5% vs. prior 93-94%. Paramount churn and December cyber incident cited. 3-4 quarter recovery expected but no interim milestones provided. Group business is 70% of revenue; sustained retention pressure would erode market share and pricing power.

Same-store growth structural decline unaddressed

Medium

Group same-store growth halved from 13-14% to 7-8%, attributed to IT-ITeS headcount saturation and benefit inflation. Management framed as industry-wide but offered no offset. If this is permanent, core growth ceiling is now 8-10% at best, far below prior 14% benchmark.

Guidance reset without numeric targets

Medium

Prior call: '14% industry growth or better.' This call: 'per or faster than market' (no number). Margin target remains 22-23% but requires 180+ bps uplift from current 20.4%. Lack of specificity reduces accountability and visibility.

Technology monetization delayed and early-stage

Medium

Platform revenue only ₹19.8 Cr H1 (4.2% of consolidated), growing strongly (69.8%) but still far from 10% target. Management states contracts are 'kicking in slowly' with 5-10x revenue-per-claim potential unproven. At current run-rate, technology won't be material for 2+ years.

How the market is positioned

The stock fell to ₹285.75, now trading 60% below its all-time high of ₹716.15 and below all major moving averages (SMA20 ₹295.45, SMA50 ₹312.48, SMA200 ₹352.12). RSI at 37.3 signals neutral-to-oversold, but volume is increasing—a sign of selling pressure, not capitulation. FII holdings increased 1.1 percentage points Q/Q to 25.42%, suggesting modest accumulation into weakness, while DII trimmed 1.95 percentage points to 47.24%. The bulk deal by NT Asian Discovery Master Fund at ₹356.76 (21% above current price) hints at institutional support, but the downtrend from ATH remains intact. The market's verdict: the margin recovery was delivered as promised, but the revenue miss and guidance reset are material misses. Price action confirms the fundamental read—growth deceleration is not priced as temporary.

What to watch next

Three concrete milestones that resolve the debate
  • 1 · Q3 TPA revenue growth and contract liability realization

    If revenue recognition catch-up from contract liability (₹321.7 Cr) materializes in Q3-Q4 as management claims, TPA revenue should accelerate meaningfully. Track whether Q3 TPA growth accelerates above 8-10%—if it stays below 5%, the accounting lag narrative breaks and growth is structurally soft.

  • 2 · Retention trajectory in Q3-Q4 FY27

    Management expects retention to recover to 93-94% in 3-4 quarters. Q3 results will show whether the trend reversed in H2. If retention stays at 90% or deteriorates further, the 3-4 quarter recovery claim is invalid and competitive pressure runs deeper.

  • 3 · Technology contract revenue realization

    Four new insurer contracts onboarded this quarter with claimed 5-10x revenue-per-claim potential. Q3-Q4 will show whether these begin translating to material revenue, or if monetization remains stuck in 'early days' narrative. Technology must reach 6-7% of revenue by H1 FY28 to be on track to the 10% target.

The rating

Hold. Medi Assist delivered on margin recovery and demonstrated operational execution (Paramount integration, zero debt, strong balance sheet). But the revenue miss is material: Q2 operating revenue grew 3.9% against a prior claim of '14% industry growth or better,' and the core TPA business expanded just 1.2%, the slowest in recent memory. Management's '3-4 quarter recovery' narrative—for retention, revenue recognition timing, and margin uplift—is a hope pattern without interim milestones. Same-store growth has halved from 13-14% to 7-8% with no offset strategy. Technology is a multi-year play, not a near-term catalyst. The market has repriced the stock 60% from ATH, below all major moving averages, and volume is increasing. Retain for long-term believers in the Paramount integration and technology platform, but do not add until growth stabilizes above mid-single digits and management provides quantified guidance. The single number to track: Q3 TPA revenue growth—if that stays below 8%, the consensus case breaks.

Medi Assist's Q2 was a steady quarter masked by margin recovery. The margin expansion was real and delivered on the Paramount integration promise. But the revenue stall is undeniable—TPA growth only 1.2% Q2 is not a timing issue, it's a signal that the core business is decelerating structurally. Retention is down, same-store growth is halved, and management has reset guidance without providing numbers. The '3-4 quarter recovery' narrative needs verification in Q3, especially on revenue recognition catch-up and retention reversal. Hold pending clarity on whether growth can stabilize above mid-single digits.

Informational and educational content only. Not investment advice.